BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28011707)

  • 1. Fatty acid binding profile of the liver X receptor α.
    Bedi S; Hines GV; Lozada-Fernandez VV; de Jesus Piva C; Kaliappan A; Rider SD; Hostetler HA
    J Lipid Res; 2017 Feb; 58(2):393-402. PubMed ID: 28011707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
    J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha.
    Hu T; Foxworthy P; Siesky A; Ficorilli JV; Gao H; Li S; Christe M; Ryan T; Cao G; Eacho P; Michael MD; Michael LF
    Endocrinology; 2005 Dec; 146(12):5380-7. PubMed ID: 16123164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands.
    Hostetler HA; Petrescu AD; Kier AB; Schroeder F
    J Biol Chem; 2005 May; 280(19):18667-82. PubMed ID: 15774422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes.
    Kase ET; Andersen B; Nebb HI; Rustan AC; Thoresen GH
    Biochim Biophys Acta; 2006 Dec; 1761(12):1515-22. PubMed ID: 17055780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Role of Liver X Receptor (LXR)
    Hansmann E; Mennillo E; Yoda E; Verreault M; Barbier O; Chen S; Tukey RH
    Drug Metab Dispos; 2020 Apr; 48(4):255-263. PubMed ID: 31980500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
    Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha).
    Hostetler HA; Kier AB; Schroeder F
    Biochemistry; 2006 Jun; 45(24):7669-81. PubMed ID: 16768463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
    Lin YN; Chang HY; Wang CCN; Chu FY; Shen HY; Chen CJ; Lim YP
    J Agric Food Chem; 2018 Oct; 66(42):10964-10976. PubMed ID: 30351048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioesterase activity and acyl-CoA/fatty acid cross-talk of hepatocyte nuclear factor-4{alpha}.
    Hertz R; Kalderon B; Byk T; Berman I; Za'tara G; Mayer R; Bar-Tana J
    J Biol Chem; 2005 Jul; 280(26):24451-61. PubMed ID: 15870076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities.
    Oswal DP; Balanarasimha M; Loyer JK; Bedi S; Soman FL; Rider SD; Hostetler HA
    J Lipid Res; 2013 Sep; 54(9):2354-65. PubMed ID: 23797899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-regulated heterodimerization of peroxisome proliferator-activated receptor α with liver X receptor α.
    Balanarasimha M; Davis AM; Soman FL; Rider SD; Hostetler HA
    Biochemistry; 2014 Apr; 53(16):2632-43. PubMed ID: 24713062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
    Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
    J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.
    Schroeder F; Huang H; Hostetler HA; Petrescu AD; Hertz R; Bar-Tana J; Kier AB
    Lipids; 2005 Jun; 40(6):559-68. PubMed ID: 16149734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional interactions between nuclear receptor LXRα and the forkhead box transcription factor FOXA2 regulate the response of the human lipoprotein lipase gene to oxysterols in hepatic cells.
    Kanaki M; Tiniakou I; Thymiakou E; Kardassis D
    Biochim Biophys Acta Gene Regul Mech; 2017 Aug; 1860(8):848-860. PubMed ID: 28576574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of hepatic acyl-CoA-binding protein and liver fatty acid-binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long-chain acyl-CoA levels.
    Sterchele PF; Vanden Heuvel JP; Davis JW; Shrago E; Knudsen J; Peterson RE
    Biochem Pharmacol; 1994 Aug; 48(5):955-66. PubMed ID: 8093108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of type 1 iodothyronine deiodinase by LXRα.
    Sakane Y; Kanamoto N; Yamauchi I; Tagami T; Morita Y; Miura M; Sone M; Yasoda A; Kimura T; Nakao K; Inagaki N
    PLoS One; 2017; 12(6):e0179213. PubMed ID: 28617824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells.
    Huang H; Starodub O; McIntosh A; Atshaves BP; Woldegiorgis G; Kier AB; Schroeder F
    Biochemistry; 2004 Mar; 43(9):2484-500. PubMed ID: 14992586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of activation of liver X receptor alpha on cardiac & hepatic ABCC10 and SLC17A5 drug transporters in hypercholesterolemic rat model.
    El-Ashmawy NE; Khedr NF; Sallam M; Nossier AI
    Biochem Biophys Res Commun; 2022 Jun; 610():133-139. PubMed ID: 35462094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.